ADMA · Adma Biologics, Inc. · Executive Compensation

$10.11 +0.39 (+4.01%) At close · Oct 5

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$2.20B

223.98M

Volume · Oct 5 3.51M Avg daily vol (3M) 2.63M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Adam Grossman	President, Chief Executive Officer and Director	$925,000	—	$4,049,994	$4,049,998	$1,156,250	$56,084	$10,237,326
Kaitlin Kestenberg	Chief Operating Officer & Senior Vice President, Compliance	$575,000	—	$1,249,989	$1,249,999	$359,375	$54,284	$3,488,647
Brad L. Tade	Former Executive Vice President and Chief Financial Officer	$500,000	—	$999,988	$999,997	$250,000	$73,645	$2,823,630
Paul Terence Kohler	Current Chief Financial Officer and Treasurer	$19,231	—	$1,124,988	$1,124,988	$15,750	$11,992	$2,296,949

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Adam Grossman	President, Chief Executive Officer and Director	$800,000	—	$3,011,731	$3,042,274	$1,020,000	$44,729	$7,918,734
Kaitlin Kestenberg	Chief Operating Officer & Senior Vice President of Compliance	$433,137	—	$1,257,773	$1,266,439	$345,000	$37,671	$3,340,020
Brad L. Tade	Chief Financial Officer and Treasurer	$374,792	—	$1,253,192	$1,002,292	$254,475	$51,684	$2,936,435
Paul Terence Kohler	Current Chief Financial Officer and Treasurer	—	—	—	—	—	—	—

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Adam Grossman	Director, President, Chief Executive Officer and Interim Chief Financial Officer	$750,000	$793,125	$1,921,878	$2,527,844	—	$46,802	$6,039,649
Brian Lenz	Former Executive Vice President and Chief Financial Officer	$475,000	$334,875	$452,836	$595,607	—	$107,042	$1,965,360
Brad L. Tade	Chief Financial Officer and Treasurer	—	—	—	—	—	—	—
Paul Terence Kohler	Current Chief Financial Officer and Treasurer	—	—	—	—	—	—	—
Kaitlin Kestenberg	Chief Operating Officer & Senior Vice President of Compliance	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Adam Grossman	Director, President, Chief Executive Officer and Interim Chief Financial Officer	$636,540	$837,351	$501,000	$629,064	—	$45,545	$2,649,501
Brian Lenz	Former Executive Vice President and Chief Financial Officer	$445,578	$471,755	$229,625	$288,321	—	$165,785	$1,601,064
Kaitlin Kestenberg	Chief Operating Officer & Senior Vice President of Compliance	—	—	—	—	—	—	—
Brad L. Tade	Chief Financial Officer and Treasurer	—	—	—	—	—	—	—

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Adam Grossman	Director, President and Chief Executive Officer	$618,000	$731,142	$2,294,903	$673,859	—	$43,346	$4,361,250
Brian Lenz	Executive Vice President and Chief Financial Officer	$432,600	$420,284	$1,146,250	$204,200	—	$163,346	$2,366,680

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Adam Grossman	Director, President and Chief Executive Officer	$600,000	$486,000	$291,500	$544,517	—	$40,124	$1,962,141
Dr. James Mond	Former Executive Vice President, Chief Scientific Officer and Chief Medical Officer	$440,000	$233,200	$116,600	$167,544	—	$238,004	$1,195,348
Brian Lenz	Executive Vice President and Chief Financial Officer	$420,000	$222,600	$116,600	$167,544	—	$160,274	$1,087,018

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Adam Grossman	Director, President and Chief Executive Officer	$536,000	$368,500	—	$760,858	—	$36,664	$1,702,022
Dr. James Mond	Executive Vice President, Chief Scientific Officer and Chief Medical Officer	$415,000	$207,500	—	$380,429	—	$234,493	$1,237,422
Brian Lenz	Executive Vice President and Chief Financial Officer	$390,000	$195,000	—	$380,429	—	$156,725	$1,122,154

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Adam Grossman	Director, President and Chief Executive Officer	$536,000	$215,205	—	$728,537	—	$73,558	$1,553,300
Dr. James Mond	Executive Vice President, Chief Scientific Officer and Chief Medical Officer	$401,800	$117,325	—	$312,230	—	$214,094	$1,045,449
Brian Lenz	Executive Vice President and Chief Financial Officer	$366,800	$107,105	—	$312,230	—	$153,959	$940,094

Executive changes

Person	Role	Change	Effective	Filed
Terry Kohler	Chief Financial Officer and Treasurer	Appointed	—	2026-02-25
Brad Tade	Chief Financial Officer and Treasurer	Retired	—	2026-02-25
Terry Kohler	Chief Financial Officer and Treasurer	Appointed	2026-02-26	2026-02-25
Brad Tade	Chief Financial Officer and Treasurer	Retired	2026-02-25	2026-02-25
Eduardo Rene Salas	Class I director	Appointed	2024-12-30	2025-01-02
Alison C. Finger	member of the Company's Governance and Nominations Committee and Compensation Committee	Appointed	2024-11-19	2024-11-21
Young T. Kwon, PhD	Chairman of the Company's Audit Committee	Appointed	2024-11-19	2024-11-21
Steven A. Elms	member of the Company's Audit Committee	Appointed	2024-11-19	2024-11-21
Bryant E. Fong	member of the Company's Board of Directors	Resigned	2024-11-19	2024-11-21
Brad Tade	Chief Financial Officer and Treasurer	Appointed	2024-07-24	2024-07-26
Kaitlin Kestenberg	Chief Operating Officer and Senior Vice President, Compliance	Appointed	2024-04-01	2024-04-02
Adam Grossman	Interim Chief Financial Officer	Appointed	2024-04-01	2024-02-28
Alison C. Finger	Class I director	Appointed	2023-09-28	2023-10-02

Key facts CIK 1368514 CUSIP 000899104 13F (30d) 10 filings 7 filers Visit website Investor relations